Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Clin Lipidol. 2011 Aug 1;6(4):371–387. doi: 10.2217/clp.11.37

Figure 3. Changes in lipid subfractions by lipid- and glucose-lowering therapies in patients with diabetes.

Figure 3

Mean percentage changes are reported when multiple studies for any particular therapy were available. Data for all lipid parameters was not available for each therapy. apoB: Apolipoprotein B; MET: Metformin; PIO: Pioglitazone; ROS: Rosiglitazone; sdLDL: Small, dense LDL; SU: Sulfonylurea; TLC: Therapeutic lifestyle changes.